1-2 of 2
Fabienne Vacheret, MD
Close
Sort by
Journal Articles

Efficacy and Safety of Erythropoietic-Stimulating Agents with Ruxolitinib in Myelofibrosis Patients : A Retrospective Analysis on 45 Patients. on Behalf of the French Intergroup of Myeloproliferative Disorders (FIM)

Sandra Malak, MD, Pascale Cony-Makhoul, MD, Jean-Christophe Ianotto, MD, Dana Ranta, MD, Philippe Rodon, MD, Fabienne Vacheret, MD, Barraco Fiorenza, MD, Francoise Boyer, MD, Katell Le Du, MD, Loic Garcon, MD PhD, Francois Lefrere, MD, Mathieu Wemeau, MD, Valerie Ugo, MD PhD, Jean-Jacques Kiladjian, MD PhD, Lydia Roy, MD
Journal: Blood
Blood (2016) 128 (22): 3123.
https://doi.org/10.1182/blood.V128.22.3123.3123
Published: 2016
Journal Articles

Myelofibrosis in Real Life: Findings from the French Intergroup of Myeloproliferative Neoplasms (FIM) Registry

Brigitte Dupriez, MD, Sylvie Chevret, MD PhD, Jean-Christophe Ianotto, MD, Francoise Boyer, MD, Pascale Cony-Makhoul, MD, Gabriel Etienne, MD PhD, Mathieu Wemeau, MD, Jérome Rey, Laurent Knoops, MD PhD, Jean-Loup Demory, MD, Eric Lippert, PhD, Francois Girodon, MD PhD, Laurence Legros, MDPhD, Anne Vekhoff, MD, Stephane Courby, MD, Fabienne Vacheret, MD, Nathalie Cambier, MD, Stephane Giraudier, MD PhD, Suzanne Tavitian, MD, Kamel Laribi, Sandra Malak, Dana Ranta, MD, Fiorenza Barraco, MD, Isabelle Plantier, MD, Sophie Dupire, Marc Simon, MD, Selim Corm, MD, Ahmad AL Jijakli, MD, Philippe Rodon, MD, Lise Willems, MD PhD, Bohrane Slama, MD, Ronan Le Calloch, MD, Pierre Morel, MD, Valerie Ugo, MD PhD, Jean-Jacques Kiladjian, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3128.
https://doi.org/10.1182/blood.V128.22.3128.3128
Published: 2016